What do systematic reviews say?

Pelvic floor muscle training vs control

• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women 2018 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 185 participants
  Moderate

Pelvic floor muscle training vs control

• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women 2018 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 7 participants
  Moderate

Pelvic floor muscle training vs control

• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 6 participants
  Low

Pelvic floor muscle training vs control

Pelvic floor muscle training probably leads to higher participant‐perceived cure after treatment Treatment duration: 8–12… compared with control (moderate certainty).

• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women 2018 · Cochrane Headline outcomes only
  RR 5.34 [2.78, 10.26]
  3 studies · 290 participants
  Moderate

Pelvic floor muscle training vs control

Pelvic floor muscle training probably leads to higher participant‐perceived cure or improvement after treatment Treatment… compared with control (moderate certainty).

• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women 2018 · Cochrane Headline outcomes only
  RR 2.39 [1.64, 3.47]
  2 studies · 166 participants
  Moderate

Pelvic floor muscle training vs control

• Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women 2018 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 349 participants
  Moderate

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  17 studies · 355 participants
  Very low

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 64 participants
  Very low

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 88 participants
  Very low

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 1062 participants
  High

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 1882 participants
  High

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  25 studies · 1521 participants
  Very low

Intervention not reported

• Antigen‐specific active immunotherapy for ovarian cancer 2018 · Cochrane Headline outcomes only
  no estimate extracted
  40 studies · 966 participants
  Very low

Progressive computer glasses vs monofocal computer glasses

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 186 participants
  Low

Progressive computer glasses with far distance focus vs bifocal computer lenses

It is very uncertain whether progressive computer glasses with far distance focus changes headache (improvement of symptoms after 4 weeks) compared with bifocal computer lenses (very low certainty).

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  OR 1.43 [0.27, 7.55]
  1 study · 36 participants
  Very low

Progressive computer glasses with far distance focus vs bifocal computer lenses

It is very uncertain whether progressive computer glasses with far distance focus changes nausea (improvement of symptoms after 4 weeks) compared with bifocal computer lenses (very low certainty).

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  RR 1.29 [0.68, 2.45]
  1 study · 8 participants
  Very low

Progressive computer glasses with far distance focus vs bifocal computer lenses

It is very uncertain whether progressive computer glasses with far distance focus changes dizziness (improvement of symptoms after 4 weeks) compared with bifocal computer lenses (very low certainty).

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  RR 1 [0.25, 4]
  1 study · 8 participants
  Very low

Progressive computer glasses with far distance focus vs trifocal computer glasses

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  Very low

Progressive computer glasses with far distance focus vs trifocal computer glasses

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  Very low

Progressive computer glasses with far distance focus vs monofocal computer glasses

• Optical correction of refractive error for preventing and treating eye symptoms in computer users 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 64 participants
  Low